First Trust NYSE Arca Biotechnology Index Fund -- Insider Buying Index Registering 16.6%
November 17, 2017 at 10:36 AM EST
A look at the weighted underlying holdings of the First Trust NYSE Arca Biotechnology Index Fund (FBT) shows an impressive 16.6% of holdings on a weighted basis have experienced insider buying within the past six months. Start slideshow:10 ETFs With Stocks That Insiders Are Buying Juno Therapeutics Inc (JUNO), which makes up 4.64% of the First Trust NYSE Arca Biotechnology Index Fund (FBT), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data.